Bio-Techne (NASDAQ:TECH) Upgraded to “Buy” at StockNews.com
StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Free Report) from a hold rating to a buy rating in a report released on Friday morning. Other research analysts have also recently issued research reports about the company. Citigroup decreased their price target on Bio-Techne from $80.00 to $70.00 and set a “neutral” rating on the stock […]
